HUMANA INC HUM
Last close
401.54
2026-09-04
Market cap
$48.21B
2026-03-31 share count
52-week range
163.11 - 428.88
Valuation FY2025 figures against the last close
P/S8.3x
P/E40.8x
P/FCF128.6x
EV/EBITDA11.7x
Dividend yield0.9%
Diluted EPS9.84
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.83B | $4.43B | $4.03B | $4.78B | $3.06B | $1.81B | $1.44B | $1.46B | $982.0M | $969.0M |
| SG&A | $15.45B | $13.70B | $13.19B | $12.67B | $10.12B | $10.05B | $7.38B | $7.53B | $6.57B | $7.17B |
| Operating income | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B |
| Interest expense | $631.0M | $660.0M | $493.0M | $401.0M | $326.0M | $283.0M | $242.0M | $218.0M | $242.0M | $189.0M |
| Pre-tax income | $1.44B | $1.62B | $3.33B | $3.57B | $3.42B | $4.67B | $3.47B | $2.07B | $4.02B | $1.55B |
| Income tax | $250.0M | $413.0M | $836.0M | $762.0M | $485.0M | $1.31B | $763.0M | $391.0M | $1.57B | $938.0M |
| Net income | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614.0M |
| EPS, basic | 9.87 | 10.01 | 20.09 | 22.20 | 22.79 | 25.47 | 20.20 | 12.24 | 16.94 | 4.11 |
| EPS, diluted | 9.84 | 9.98 | 20.00 | 22.08 | 22.67 | 25.31 | 20.10 | 12.16 | 16.81 | 4.07 |
| Shares, diluted (wtd. avg.) | $120.8M | $120.9M | $124.4M | $127.1M | $129.4M | $133.0M | $134.7M | $138.4M | $145.6M | $150.9M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $4.20B | $2.22B | $4.69B | $5.06B | $3.39B | $4.67B | $4.05B | $2.34B | $4.04B | $3.88B |
| Short-term investments | $15.70B | $18.21B | $16.63B | $13.88B | $13.19B | $12.55B | $10.97B | $10.03B | $9.56B | $7.59B |
| Receivables | $3.27B | $2.70B | $2.04B | $1.67B | $1.81B | $1.14B | $1.06B | $1.01B | $854.0M | $1.28B |
| Total current assets | $32.73B | $29.82B | $29.99B | $26.18B | $24.89B | $23.64B | $19.89B | $16.95B | $17.40B | $16.19B |
| Property, plant and equipment | $2.23B | $2.53B | $3.03B | $3.22B | $3.07B | $2.37B | $1.96B | $1.74B | $1.58B | $1.50B |
| Goodwill | $9.69B | $9.63B | $9.55B | $9.14B | $11.09B | $4.45B | $3.93B | $3.90B | $3.28B | $3.27B |
| Other intangibles | $1.13B | $1.44B | $1.69B | $1.76B | $2.64B | $329.0M | $177.0M | $245.0M | $226.0M | $280.0M |
| Total assets | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B |
| Accounts payable | $5.72B | $5.26B | $6.57B | $5.24B | $4.51B | $4.01B | $3.75B | $3.07B | $4.07B | $2.47B |
| Short-term debt | $0 | $577.0M | $1.44B | $2.09B | $1.95B | $600.0M | $699.0M | $1.69B | $150.0M | $300.0M |
| Total current liabilities | $16.35B | $16.94B | $18.87B | $17.18B | $15.33B | $13.39B | $10.93B | $10.08B | $9.41B | $7.82B |
| Long-term debt | $12.37B | $11.14B | $10.21B | $9.03B | $10.54B | $6.06B | $4.97B | $4.38B | $4.77B | $3.79B |
| Total liabilities | $31.17B | $30.03B | $30.75B | $27.68B | $28.25B | $21.24B | $17.04B | $15.25B | $17.34B | $14.71B |
| Retained earnings | $29.07B | $28.32B | $27.54B | $25.49B | $23.09B | $20.52B | $17.48B | $15.07B | $13.67B | $11.45B |
| Total equity | $17.66B | $16.38B | $16.32B | $15.37B | $16.10B | $13.73B | $12.04B | $10.16B | $9.84B | $10.69B |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $921.0M | $2.97B | $3.98B | $4.59B | $2.26B | $5.64B | $5.28B | $2.17B | $4.05B | $1.94B |
| Depreciation and amortisation | $773.0M | $908.0M | $850.0M | $749.0M | $640.0M | $528.0M | $505.0M | $444.0M | $410.0M | $388.0M |
| Stock-based compensation | $241.0M | $207.0M | $175.0M | $216.0M | $180.0M | $181.0M | $163.0M | $137.0M | $157.0M | $115.0M |
| Capital expenditure | $546.0M | $575.0M | $1.00B | $1.14B | $1.34B | $964.0M | $736.0M | $612.0M | $524.0M | $527.0M |
| Investing cash flow | $2.27B | -$2.95B | -$3.49B | -$1.01B | -$6.56B | -$3.06B | -$1.28B | -$3.09B | -$2.94B | -$1.36B |
| Financing cash flow | -$1.22B | -$2.49B | -$856.0M | -$1.91B | $3.02B | -$1.96B | -$2.29B | -$785.0M | -$945.0M | $732.0M |
| Dividends paid | $430.0M | $431.0M | $431.0M | $392.0M | $354.0M | $323.0M | $291.0M | $265.0M | $220.0M | $177.0M |
| Buybacks | $151.0M | $817.0M | $1.57B | $2.10B | $79.0M | $1.82B | $1.07B | $1.09B | $3.37B | $104.0M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0000049071-26-000009.
Others in SIC 6324
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | $356.47B | 30.0x | 11.8% |
| ELV | Elevance Health, Inc. | $88.37B | 16.2x | 12.5% |
| CI | Cigna Group | $74.65B | 12.7x | 11.2% |
| CNC | CENTENE CORP | $33.12B | — | 20.0% |
| MOH | MOLINA HEALTHCARE, INC. | $10.48B | 22.5x | 11.7% |
| OSCR | Oscar Health, Inc. | $9.75B | — | 39.0% |
| ALHC | Alignment Healthcare, Inc. | $2.81B | — | 46.1% |
| CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | $2.23B | — | 40.3% |